Global Herpes Zoster Infection Treatment Market is Segmented by Drug Type (Antivirals, Analgesic, Non-Steroidal Anti-inflammatory drug and others); by Vaccination Type (Monovalent and Combination); by End user (Hospitals and clinics, Diagnostic centers and others), Regional Forecasts 2021-2027
- BIZ4639374
- 200 Pages
- September 2021
- Pharmaceuticals
Herpes Zoster, also known as shingles, is a viral infection that causes painful rashes on skin. Herpes Zoster is caused by the Varicella zoster virus, it is the same that causes Chicken pox as well. After the person has had chicken pox, the virus lies dormant in certain nerves for years and its reactivation causes Herpes Zoster Infection. Although, the infection is incurable, vaccines are available to prevent shingles and long-lasting nerve pain that sometimes develops. Herpes Zoster can affect anybody with weak immune system; it is more likely to be found in people aged over 50 years, HIV and cancer patients. The rising prevalence rate of shingles in older population and predominance of effective antibodies are the prime reasons driving the growth of herpes zoster treatment market. The herpes infection rate and increasing elderly population are fueling the overall demand of the market. For instance, according to the National Foundation for Infectious Diseases, about 98% of the US adults have had chicken pox and are at risk of shingles. Almost 1 out of 3 people in the US will develop shingles during their lifetime.
Furthermore, there is substantial increase in research and development activities. The market is growing due to the availability of effective vaccines and drugs to keep the patient healthier and provide treatment without hospitalization. On the flip side, costly antibodies are restraining vaccination drive in developing economies. Inadequate scope of the prevention, improper reimbursement policies and lack of healthcare guidance etc. are hampering the growth of the market.
North America accounts for majority of the shares in Herpes Zoster Infection Treatment Market among all regional markets, due to increase in the government support for various vaccination and awareness programs and funds provided by them. Apart from this, Asia pacific, Middle East and Africa will emerge as fastest growing countries due to increasing prevalence of the herpes zoster disease.
Major market player included in this report are:
Bausch Health Companies Inc.
Cipla Inc.
Eli Lilly and Co.
Gilead Sciences Inc.
GlaxoSmithKline Plc
Maruho Co. Ltd.
Merck & Co. Inc.
Mylan NV
Novartis AG
Teva Pharmaceutical Industries Ltd
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug type:
Antivirals
Analgesic
Non-Steroidal Anti-inflammatory drug
others
By Vaccination type:
Monovalent
Combination
By End User:
Hospitals and clinics
Diagnostic centers
others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Herpes Zoster Infection Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Million)
1.2.1. Herpes Zoster Infection Treatment Market, by region, 2019-2027 (USD Million)
1.2.2. Herpes Zoster Infection Treatment Market, by Drug type, 2019-2027 (USD Million)
1.2.3. Herpes Zoster Infection Treatment Market, by Vaccination type, 2019-2027 (USD Million)
1.2.4. Herpes Zoster Infection Treatment Market, by End user, 2019-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Herpes Zoster Infection Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Herpes Zoster Infection Treatment Market Dynamics
3.1. Herpes Zoster Infection Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. The rising prevalence rate of shingles in older population
3.1.1.2. Predominance of effective antibodies
3.1.2. Market Challenges
3.1.2.1. High cost of antibodies
3.1.2.2. Improper reimbursement policies and lack of healthcare guidance
3.1.3. Market Opportunities
3.1.3.1. Increasing elderly population
Chapter 4. Global Herpes Zoster Infection Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Herpes Zoster Infection Treatment Market, by Drug type
5.1. Market Snapshot
5.2. Global Herpes Zoster Infection Treatment Market by Drug Type, Performance - Potential Analysis
5.3. Global Herpes Zoster Infection Treatment Market Estimates & Forecasts by Drug Type 2018-2027 (USD Million)
5.4. Herpes Zoster Infection Treatment Market, Sub Segment Analysis
5.4.1. Antivirals
5.4.2. Analgesic
5.4.3. Non-Steroidal Anti-inflammatory drug
5.4.4. others
Chapter 6. Global Herpes Zoster Infection Treatment Market, by Vaccination Type
6.1. Market Snapshot
6.2. Global Herpes Zoster Infection Treatment Market by Vaccination Type, Performance - Potential Analysis
6.3. Global Herpes Zoster Infection Treatment Market Estimates & Forecasts by Vaccination Type 2018-2027 (USD Million)
6.4. Herpes Zoster Infection Treatment Market, Sub Segment Analysis
6.4.1. Monovalent
6.4.2. Combination
Chapter 7. Global Herpes Zoster Infection Treatment Market, by End user
7.1. Market Snapshot
7.2. Global Herpes Zoster Infection Treatment Market by End user, Performance - Potential Analysis
7.3. Global Herpes Zoster Infection Treatment Market Estimates & Forecasts by End user 2018-2027 (USD Million)
7.4. Herpes Zoster Infection Treatment Market, Sub Segment Analysis
7.4.1. Hospitals and clinics
7.4.2. Diagnostic centre
7.4.3. others
Chapter 8. Global Herpes Zoster Infection Treatment Market, Regional Analysis
8.1. Herpes Zoster Infection Treatment Market, Regional Market Snapshot
8.2. North America Herpes Zoster Infection Treatment Market
8.2.1. U.S. Herpes Zoster Infection Treatment Market
8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Vaccination Type breakdown estimates & forecasts, 2018-2027
8.2.1.3. End user breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Herpes Zoster Infection Treatment Market
8.3. Europe Herpes Zoster Infection Treatment Market Snapshot
8.3.1. U.K. Herpes Zoster Infection Treatment Market
8.3.2. Germany Herpes Zoster Infection Treatment Market
8.3.3. France Herpes Zoster Infection Treatment Market
8.3.4. Spain Herpes Zoster Infection Treatment Market
8.3.5. Italy Herpes Zoster Infection Treatment Market
8.3.6. Rest of Europe Herpes Zoster Infection Treatment Market
8.4. Asia-Pacific Herpes Zoster Infection Treatment Market Snapshot
8.4.1. China Herpes Zoster Infection Treatment Market
8.4.2. India Herpes Zoster Infection Treatment Market
8.4.3. Japan Herpes Zoster Infection Treatment Market
8.4.4. Australia Herpes Zoster Infection Treatment Market
8.4.5. South Korea Herpes Zoster Infection Treatment Market
8.4.6. Rest of Asia Pacific Herpes Zoster Infection Treatment Market
8.5. Latin America Herpes Zoster Infection Treatment Market Snapshot
8.5.1. Brazil Herpes Zoster Infection Treatment Market
8.5.2. Mexico Herpes Zoster Infection Treatment Market
8.6. Rest of The World Herpes Zoster Infection Treatment Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Bausch Health Companies Inc
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Cipla Inc
9.2.3. Eli Lilly and Co
9.2.4. Gilead Sciences Inc.
9.2.5. GlaxoSmithKline Plc.
9.2.6. Maruho Co. Ltd
9.2.7. Merck & Co. Inc.
9.2.8. Mylan NV
9.2.9. Novartis AG
9.2.10. Teva Pharmaceutical Industries Ltd
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
TABLE 1. Global Herpes Zoster Infection Treatment Market, report scope
TABLE 2. Global Herpes Zoster Infection Treatment Market estimates & forecasts by region 2018-2027 (USD Million)
TABLE 3. Global Herpes Zoster Infection Treatment Market estimates & forecasts by Drug Type 2018-2027 (USD Million)
TABLE 4. Global Herpes Zoster Infection Treatment Market estimates & forecasts by Vaccination Type 2018-2027 (USD Million)
TABLE 5. Global Herpes Zoster Infection Treatment Market estimates & forecasts by End user 2018-2027 (USD Million)
TABLE 6. Global Herpes Zoster Infection Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 7. Global Herpes Zoster Infection Treatment Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 8. Global Herpes Zoster Infection Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 9. Global Herpes Zoster Infection Treatment Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 10. Global Herpes Zoster Infection Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 11. Global Herpes Zoster Infection Treatment Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 12. Global Herpes Zoster Infection Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 13. Global Herpes Zoster Infection Treatment Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 14. Global Herpes Zoster Infection Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Million)
TABLE 15. Global Herpes Zoster Infection Treatment Market by region, estimates & forecasts, 2018-2027 (USD Million)
TABLE 16. U.S. Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 17. U.S. Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 18. U.S. Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 19. Canada Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 20. Canada Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 21. Canada Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 22. UK Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 23. UK Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 24. UK Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 25. Germany Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 26. Germany Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 27. Germany Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 28. RoE Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 29. RoE Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 30. RoE Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 31. China Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 32. China Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 33. China Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 34. India Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 35. India Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 36. India Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 37. Japan Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 38. Japan Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 39. Japan Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 40. RoAPAC Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 41. RoAPAC Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 42. RoAPAC Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 43. Brazil Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 44. Brazil Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 45. Brazil Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 46. Mexico Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 47. Mexico Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 48. Mexico Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 49. RoLA Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 50. RoLA Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 51. RoLA Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 52. Row Herpes Zoster Infection Treatment Market estimates & forecasts, 2018-2027 (USD Million)
TABLE 53. Row Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 54. Row Herpes Zoster Infection Treatment Market estimates & forecasts by segment 2018-2027 (USD Million)
TABLE 55. List of secondary sources, used in the study of global Herpes Zoster Infection Treatment Market
TABLE 56. List of primary sources, used in the study of global Herpes Zoster Infection Treatment Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
